Abortion Pills

Virginia District Court Rules FDA Unlawfully Restricted Abortion Pill Access

A Virginia district court judge ordered the FDA to reconsider its restrictions on mifepristone, a highly safe and effective prescription medication for terminating early pregnancy. The judge, Robert S. Ballou, sided with reproductive health clinics in three states that argued that current restrictions are excessive, medically unnecessary, and inconsistent with federal law. The challenged restrictions are part of FDA’s 2023 risk evaluation mitigation strategy (2023 REMS).
Read More

In wide-ranging amicus briefs, experts again urge the Fifth Circuit to reject restrictions on telehealth access to mifepristone

Ahead of oral argument in Louisiana v. U.S. Food and Drug Administration (FDA) on September 9, a wide range of experts — including the American College of Obstetricians and Gynecologists, American College of Emergency Physicians, the National Domestic Violence Hotline, the Disability Rights Education & Defense Fund, the NAACP Legal Defense & Educational Fund, pharmaceutical and biotech manufacturers, and former military officials — are urging the U.S. Court of Appeals for the Fifth Circuit to reject anti-abortion politicians’ effort to end telemedicine and mail and pharmacy access to mifepristone nationwide.Mifepristone is used in nearly two-thirds of U.S. abortions, with more than 1 in 4 patients
Read More

How Todd Blanche Can Weaponize the Nation’s Top Law Enforcement Agency Against Reproductive Freedom

Todd Blanche was sworn in as Trump’s U.S. Attorney General yesterday, putting one of his closest loyalists and former personal defense attorney in charge of the nation’s top law enforcement agency. His swearing in comes as anti-abortion groups intensify pressure on the administration to restrict abortion nationwide—and Blanche has already promised to help deliver.
Read More

Federal Court Rules FDA Abortion Pill Restrictions Are Unjustified

A federal court in Virginia ruled that the Food and Drug Administration’s (FDA) restrictions on the abortion pill mifepristone are unjustified and baseless, and ordered the agency to reconsider them. In its ruling, the court said the FDA disregarded the scientific record demonstrating that mifepristone could be safely prescribed without restrictive regulations. 
Read More
No widgets found. Go to Widget page and add the widget in Offcanvas Sidebar Widget Area.